Effect of agmatine on brain l-citrulline production during morphine withdrawal in rats: A microdialysis study in nucleus accumbens

Brain Research

Volumn 1132, Issue 1, 2007, Pages 51-58

  Yananli, Hasan ^a   Gören, M Zafer ^a   Berkman, Kemal ^a   Aricioǧlu, Feyza ^b  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

Agmatine; l NAME; Microdialysis; Morphine withdrawal; NO (nitric oxide); Nucleus accumbens

Indexed keywords

AGMATINE; CITRULLINE; IMIDAZOLINE RECEPTOR; MORPHINE; N(G) NITROARGININE METHYL ESTER; NALOXONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DEFECATION; DRUG MECHANISM; JUMPING; MALE; MICRODIALYSIS; MORPHINE ADDICTION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; WET DOG SHAKES; WITHDRAWAL SYNDROME; WRITHING TEST;

AGMATINE; ANIMALS; CITRULLINE; DOWN-REGULATION; ENZYME INHIBITORS; EXTRACELLULAR FLUID; MALE; MICRODIALYSIS; MORPHINE DEPENDENCE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; SUBSTANCE WITHDRAWAL SYNDROME;

RATTUS;

EID: 33846265408     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.11.028     Document Type: Article

References (38)

1. Ari{dotless}ci{dotless}oǧlu-Kartal F., and Regunathan S. Effect of chronic morphine treatment on the biosynthesis of agmatine in rat brain and other tissues. Life Sci. 71 (2002) 1695-1701
2. Ari{dotless}ci{dotless}oǧlu-Kartal F., and Uzbay I.T. Inhibitory effect of agmatine on naloxone precipitated abstinence syndrome in morphine dependent rats. Life Sci. 61 (1997) 1775-1781
3. Ari{dotless}ci{dotless}oǧlu F., Paul I.A., and Regunathan S. Agmatine reduces only peripheral-related behavioral signs, not the central sings, of morphine withdrawal in nNOS deficient transgenic mice. Neurosci. Lett. 354 (2004) 153-157
4. Auguet M., Viossat I., Marin J.G., and Chabrier P.E. Selective inhibition of inducible nitric oxide synthase by agmatine. Jpn. J. Pharmacol. 69 (1995) 285-287
5. Avidor-Reiss T., Bayewitch M., Levy R., Matus-Leibovitch N., Nevo I., and Vogel Z. Adenylylcyclase supersensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment. J. Biol. Chem. 270 (1995) 29732-29738
6. Bhargava H.N. Attenuation of tolerance to, and physical dependence on, morphine in the rat by inhibition of nitric oxide synthase. Gen. Pharmacol. 26 (1995) 1049-1053
7. Biggs C.S., Pearce B.R., Fowler L.J., and Whitton P.S. The effect of sodium valproate on extracellular GABA and other amino acids in the rat ventral hippocampus: an in vivo microdialysis study. Brain Res. 594 (1992) 138-142
8. Bradley K.J., and Headley P.M. Effect of agmatine on spinal nociceptive reflexes: lack of interaction with alpha2-adrenoceptor or mu-opioid receptor mechanisms. Eur. J. Pharmacol. 331 (1997) 133-138
9. Cappendijk S.L., de Vries R., and Dzoljic M.R. Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Neurosci. Lett. 162 (1993) 97-100
10. Cerletti C., Keinath S.H., Reidenberg M.M., and Alder M.W. Chronic morphine administration: plasma levels and withdrawal in rats. Pharmacol. Biochem Behav. 4 3 (1976) 323-327
11. Copeland R.L., Pradhan S.N., Dillon-Carter O., and Chuang D.M. Rebound increase of basal cAMP level in NG108-15 cells during chronic morphine treatment: effects of naloxone and chloramphenicol. Life Sci. 44 (1989) 1107-1116
12. Cuellar B., Fernandez A.P., Lizasoain I., Moro M.A., Lorenzo P., Bentura M.L., Rodrigo J., and Leza J.C. Up-regulation of neuronal NO synthase immunoreactivity in opiate dependence and withdrawal. Psychopharmacology 148 (2000) 66-73
13. De Vries T.J., and S.T. Neural systems underlying opiate addiction. J. Neurosci. 22 (2002) 3321-3325
14. Feng Y., Halaris A.E., and Piletz J.E. Determination of agmatine in brain plasma using high-performance liquid chromatography with fluorence detection. J. Chromatogr. 691 (1997) 277-286
15. Galea E., Regunathan S., Eliopoulos V., Feinstein D.L., and Reis D.J. Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem. J. 316 (1996) 247-249
16. Garthwaite J., Garthwaite G., Palmer R.M., and Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmacol. 172 (1989) 413-416
17. Gonzalez P., Cabello P., Germany A., Norris B., and Contreras E. Decrease of tolerance to, and physical dependence on morphine by, glutamate receptor antagonists. Eur. J. Pharmacol. 332 (1997) 257-262
18. Guitart X., and Nestler E.J. Second messenger and protein phosphorylation mechanisms underlying opiate addiction: studies in the rat locus coeruleus. Neurochem. Res. 18 (1996) 5-13
19. Higgins G.A., Nguyen P., and Sellers E.M. The NMDA antagonist dizocilpine (MK801) attenuates motivational as well as somatic aspects of naloxone precipitated opioid withdrawal. Life Sci. 50 (1992) 167-172
20. Kalra S.P., Pearson E., Sahu A., and Kalra P.S. Agmatine, a novel hypothalamic amine, stimulates pituitary luteinizing hormone release in vivo and hypothalamic luteinizing hormone-releasing hormone release in vitro. Neurosci. Lett. 194 (1995) 165-168
21. Koyuncuoglu H., Dizdar Y., Aricioglu F., and Sayin U. Effects of MK 801 on morphine physical dependence: attenuation and intensification. Pharmacol. Biochem. Behav. 43 (1992) 487-490
22. Li G., Regunathan S., Barrow C.J., Eshraghi J., Cooper R., and Reis D.J. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 263 (1994) 966-969
23. Machelska H., Ziolkowska B., Mika J., Przewlocka B., and Przewlocki R. Chronic morphine increases biosynthesis of nitric oxide synthase in the rat spinal cord. NeuroReport 18 (1997) 2743-2747
24. Manzoni O., Prezeau L., Marin P., Deshager S., Bockaert J., and Fagni L. Nitric oxide-induced blockade of NMDA receptors. Neuron 8 (1992) 653-662
25. Mehta C.S., and Strad S.J. Effects of acute and continuous administration of morphine on the cAMP response induced by norepinephrine in rat brain slices. Life Sci. 55 (1994) 35-42
26. Nestler E.J. Molecular neurobiology of addiction. Am. J. Addict. 10 (2002) 201-217
27. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 4nd ed. (2000), Academic Press
28. Piletz J.E., Chikkala D.N., and Ernsberger P. Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. J. Pharmacol. Exp. Ther. 272 (1995) 581-587
29. Pinthong D., Hussain J.F., Kendall D.A., and Wilson V.G. Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sites. Br. J. Pharmacol. 115 (1995) 689-695 (Jun.)
30. Popik P., Mamczarz J., Fraczek M., Widla M., Hesselink M., and Danysz W. Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists. Neuropharmacology 37 (1998) 1033-1042
31. Regunathan S., and Reis D.J. Imidazoline receptors and their endogeneus ligands. Annu. Rev. Pharmacol. Toxicol. 36 (1996) 511-544
32. Regunathan S., Feinstein D.L., Raasch W., and Reis D.J. Agmatine, the decarboxylated arginine is localized and synthesized in glial cells. NeuroReport 6 (1995) 1900-1987
33. Reis D.J., and Regunathan S. Is agmatine a novel neurotransmitter in brain?. Trends Pharmacol. Sci. 21 (2000) 187-193
34. Trujillo K.A., and Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251 (1991) 85-87
35. Trujillo K.A., and Akil H. Opiate tolerance and dependence: recent findings and synthesis. New Biol. (1991) 3915-3923
36. Vaupel D.B., Kimes A.S., and London E.D. Comparison of 7-nitroindazole with other nitric oxide synthase inhibitors as attenuators of opioid withdrawal. Psychopharmacology 118 (1995) 361-368
37. Vaupel D.B., Kimes A.S., and London E.D. Further in vivo studies on attenuating morphine withdrawal: isoform selective nitric oxide synthase inhibitors differ in efficacy. Eur. J. Pharmacol. 324 (1997) 11-20
38. Yang X.-C., and Reis D.J. Agmatine selectively blocks the NMDA subclass of glutamate receptor channels in cultured mouse hippocampal neurons. J. Pharmacol. Exp. Ther. 288 (1999) 544-549